{"name":"Opal Rheumatology Ltd.","slug":"opal-rheumatology-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"Biosimilar","genericName":"Biosimilar","slug":"biosimilar","indication":"Other","status":"phase_2"},{"name":"Originator","genericName":"Originator","slug":"originator","indication":"Other","status":"phase_2"}]}],"pipeline":[{"name":"Biosimilar","genericName":"Biosimilar","slug":"biosimilar","phase":"phase_2","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"Originator","genericName":"Originator","slug":"originator","phase":"phase_2","mechanism":"Biologic","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiakFVX3lxTE5HM05WVnBaWHZKNkFRMkNnUWJENEZqQjhjNnd6dV9ld25LTjREaTkwZ18wZ1YxZTZFZmVjSU5JS1ZKUkRQNElaNUpFc3oxWHoxRG5uSk5jMHpuSWpuNHFaelFxQVNfLUd3SWc?oc=5","date":"2023-06-30","type":"trial","source":"MedPage Today","summary":"Xeljanz Edges Humira Just a Bit for Real-World RA Patients, Study Suggests - MedPage Today","headline":"Xeljanz Edges Humira Just a Bit for Real-World RA Patients, Study Suggests","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"phase_2":2},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}